Evolution from Gene Discovery to Drug Development
TL;DR
Howard Chang, a renowned genomic researcher and dermatologist, transitioned from academia and biotech startups to become Amgen's new CSO, focusing on genetic target discovery, extrachromosomal DNA, and technology development to advance drug discovery.
Topics:sciencescience-and-technology#biotech#drug-development#extrachromosomal-dna#gene-discovery#howard-chang#science-and-technology
Want the full story? Read the original reporting
Read on Nature